MacroDel biologics

Boehringer Ingelheim buys MacroDel platform developer ICD Therapeutics
Pharmaceutical Business Review
Mon, 04/1/19 - 12:19 pm
Boehringer Ingelheim
MacroDel biologics
M&A
ICD Therapeutics